Neurological Care of CNY

Liverpool, New York 13088

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Partial Epilepsy

Studies at this site

• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) — Completed
• Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — Completed